Loring Wolcott & Coolidge Fiduciary Advisors LLP Moderna, Inc. Transaction History
Loring Wolcott & Coolidge Fiduciary Advisors LLP
- $10.3 Billion
- Q1 2025
A detailed history of Loring Wolcott & Coolidge Fiduciary Advisors LLP transactions in Moderna, Inc. stock. As of the latest transaction made, Loring Wolcott & Coolidge Fiduciary Advisors LLP holds 175 shares of MRNA stock, worth $4,683. This represents 0.0% of its overall portfolio holdings.
Number of Shares
175
Previous 175
-0.0%
Holding current value
$4,683
Previous $7,000
42.86%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding MRNA
# of Institutions
872Shares Held
255MCall Options Held
24MPut Options Held
31.3M-
Vanguard Group Inc Valley Forge, PA40.4MShares$1.08 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$684 Million0.07% of portfolio
-
Baillie Gifford & CO24.9MShares$668 Million0.64% of portfolio
-
State Street Corp Boston, MA17.8MShares$476 Million0.02% of portfolio
-
Geode Capital Management, LLC Boston, MA7.46MShares$200 Million0.02% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $10.5B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...